CD4 and COVID-19: In contrast, a recent study conducted by the WHO Global Clinical Platform for COVID-19 found only modest reduction in mortality risk with Omicron compared to Delta infection among PLHIV, though this did not specifically comment on pregnant populations and cited risk factors of low CD4 and older age [24].